FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2049848314> ?p ?o ?g. }

• W2049848314 endingPage "1170" @default.
• W2049848314 startingPage "1165" @default.
• W2049848314 abstract "Purpose A postmarketing surveillance registry was conducted to monitor the safety and effectiveness of the OptEase vena cava filter when used as a permanent filter. Materials and Methods This study was a nonrandomized, multicenter prospective trial with all patients receiving the OptEase vena cava filter for the prevention of pulmonary embolism (PE). A total of 11 clinical sites in the United States enrolled patients. A 1-month postimplantation follow-up examination was performed to determine potential filter migration and the presence of symptomatic thrombosis of the inferior vena cava (IVC) or lower extremities. At 6-month postimplantation follow-up, patients were again assessed for the safety and stability of the filter and any clinical evidence of symptomatic thrombosis. Results One hundred fifty patients were enrolled in this study. Fifty-five patients (36.6%) were unable to complete all of the necessary follow-up at 6 months. At 1 month, filter migration and filter-related symptomatic deep vein thrombosis was observed in one patient each (0.9% and 0.8%, respectively). At 6 months, no new cases of filter migration or filter-related symptomatic thrombosis were observed. Filter tilting (≥15° off the IVC axis) was observed in one patient at baseline (0.7%), four patients at 1-month follow-up (3.6%), and three patients (11.4%) at 6-month follow-up. Incidental findings on follow-up radiographs included filter fracture in two patients (1.8%) at 1 month and in one additional patient (4.3%) at 6 months. There were no clinical sequelae associated with the filter fracture. Conclusions The co-primary endpoints of filter migration and symptomatic thrombus formation at 1 month had an observed frequency of 0.9% and 0.8%, respectively. These co-primary endpoints were stable and unchanged at 6 months. A postmarketing surveillance registry was conducted to monitor the safety and effectiveness of the OptEase vena cava filter when used as a permanent filter. This study was a nonrandomized, multicenter prospective trial with all patients receiving the OptEase vena cava filter for the prevention of pulmonary embolism (PE). A total of 11 clinical sites in the United States enrolled patients. A 1-month postimplantation follow-up examination was performed to determine potential filter migration and the presence of symptomatic thrombosis of the inferior vena cava (IVC) or lower extremities. At 6-month postimplantation follow-up, patients were again assessed for the safety and stability of the filter and any clinical evidence of symptomatic thrombosis. One hundred fifty patients were enrolled in this study. Fifty-five patients (36.6%) were unable to complete all of the necessary follow-up at 6 months. At 1 month, filter migration and filter-related symptomatic deep vein thrombosis was observed in one patient each (0.9% and 0.8%, respectively). At 6 months, no new cases of filter migration or filter-related symptomatic thrombosis were observed. Filter tilting (≥15° off the IVC axis) was observed in one patient at baseline (0.7%), four patients at 1-month follow-up (3.6%), and three patients (11.4%) at 6-month follow-up. Incidental findings on follow-up radiographs included filter fracture in two patients (1.8%) at 1 month and in one additional patient (4.3%) at 6 months. There were no clinical sequelae associated with the filter fracture. The co-primary endpoints of filter migration and symptomatic thrombus formation at 1 month had an observed frequency of 0.9% and 0.8%, respectively. These co-primary endpoints were stable and unchanged at 6 months." @default.
• W2049848314 created "2016-06-24" @default.
• W2049848314 creator A5007202415 @default.
• W2049848314 creator A5016363507 @default.
• W2049848314 creator A5018192421 @default.
• W2049848314 creator A5055664237 @default.
• W2049848314 creator A5062540026 @default.
• W2049848314 creator A5068410656 @default.
• W2049848314 date "2008-08-01" @default.
• W2049848314 modified "2023-09-27" @default.
• W2049848314 title "PROOF Trial: Protection from Pulmonary Embolism with the OptEase Filter" @default.
• W2049848314 cites W1973383857 @default.
• W2049848314 cites W1980150722 @default.
• W2049848314 cites W1983866625 @default.
• W2049848314 cites W1991709476 @default.
• W2049848314 cites W1995096049 @default.
• W2049848314 cites W2007050503 @default.
• W2049848314 cites W2011389832 @default.
• W2049848314 cites W2013728670 @default.
• W2049848314 cites W2025869180 @default.
• W2049848314 cites W2037018509 @default.
• W2049848314 cites W2041756222 @default.
• W2049848314 cites W2087080512 @default.
• W2049848314 cites W2087646765 @default.
• W2049848314 cites W2088320421 @default.
• W2049848314 cites W2090735669 @default.
• W2049848314 cites W2117970704 @default.
• W2049848314 cites W2146311079 @default.
• W2049848314 cites W2153510943 @default.
• W2049848314 cites W2156774791 @default.
• W2049848314 cites W4237864994 @default.
• W2049848314 cites W4247841191 @default.
• W2049848314 cites W4301359359 @default.
• W2049848314 doi "https://doi.org/10.1016/j.jvir.2008.04.020" @default.
• W2049848314 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18656008" @default.
• W2049848314 hasPublicationYear "2008" @default.
• W2049848314 type Work @default.
• W2049848314 sameAs 2049848314 @default.
• W2049848314 citedByCount "36" @default.
• W2049848314 countsByYear W20498483142012 @default.
• W2049848314 countsByYear W20498483142013 @default.
• W2049848314 countsByYear W20498483142014 @default.
• W2049848314 countsByYear W20498483142016 @default.
• W2049848314 countsByYear W20498483142018 @default.
• W2049848314 countsByYear W20498483142019 @default.
• W2049848314 countsByYear W20498483142020 @default.
• W2049848314 countsByYear W20498483142021 @default.
• W2049848314 countsByYear W20498483142023 @default.
• W2049848314 crossrefType "journal-article" @default.
• W2049848314 hasAuthorship W2049848314A5007202415 @default.
• W2049848314 hasAuthorship W2049848314A5016363507 @default.
• W2049848314 hasAuthorship W2049848314A5018192421 @default.
• W2049848314 hasAuthorship W2049848314A5055664237 @default.
• W2049848314 hasAuthorship W2049848314A5062540026 @default.
• W2049848314 hasAuthorship W2049848314A5068410656 @default.
• W2049848314 hasConcept C126322002 @default.
• W2049848314 hasConcept C126838900 @default.
• W2049848314 hasConcept C141071460 @default.
• W2049848314 hasConcept C188816634 @default.
• W2049848314 hasConcept C2776265017 @default.
• W2049848314 hasConcept C2778959117 @default.
• W2049848314 hasConcept C2780011451 @default.
• W2049848314 hasConcept C2780828045 @default.
• W2049848314 hasConcept C2780868729 @default.
• W2049848314 hasConcept C2910216633 @default.
• W2049848314 hasConcept C535046627 @default.
• W2049848314 hasConcept C71924100 @default.
• W2049848314 hasConceptScore W2049848314C126322002 @default.
• W2049848314 hasConceptScore W2049848314C126838900 @default.
• W2049848314 hasConceptScore W2049848314C141071460 @default.
• W2049848314 hasConceptScore W2049848314C188816634 @default.
• W2049848314 hasConceptScore W2049848314C2776265017 @default.
• W2049848314 hasConceptScore W2049848314C2778959117 @default.
• W2049848314 hasConceptScore W2049848314C2780011451 @default.
• W2049848314 hasConceptScore W2049848314C2780828045 @default.
• W2049848314 hasConceptScore W2049848314C2780868729 @default.
• W2049848314 hasConceptScore W2049848314C2910216633 @default.
• W2049848314 hasConceptScore W2049848314C535046627 @default.
• W2049848314 hasConceptScore W2049848314C71924100 @default.
• W2049848314 hasIssue "8" @default.
• W2049848314 hasLocation W20498483141 @default.
• W2049848314 hasLocation W20498483142 @default.
• W2049848314 hasOpenAccess W2049848314 @default.
• W2049848314 hasPrimaryLocation W20498483141 @default.
• W2049848314 hasRelatedWork W2126095206 @default.
• W2049848314 hasRelatedWork W2352976444 @default.
• W2049848314 hasRelatedWork W2383158841 @default.
• W2049848314 hasRelatedWork W2394146558 @default.
• W2049848314 hasRelatedWork W2978115577 @default.
• W2049848314 hasRelatedWork W3031791182 @default.
• W2049848314 hasRelatedWork W3032065286 @default.
• W2049848314 hasRelatedWork W3111527613 @default.
• W2049848314 hasRelatedWork W4313544693 @default.
• W2049848314 hasRelatedWork W3029963180 @default.
• W2049848314 hasVolume "19" @default.
• W2049848314 isParatext "false" @default.
• W2049848314 isRetracted "false" @default.
• W2049848314 magId "2049848314" @default.

• next